Vedolizumab in children with IBD
Neuroimmune modulation through vagus nerve stimulation in CD
Golimumab, Guselkumab or both in UC
Mesalamine multimatrix in pediatric UC
5-ASA in CD maintenance
Adalimumab increased interval in CD
Upadacitinib maintenance in moderate-severe UC
Mirikizumab induction and maintenance
Ritlecitinib and Brepocitinib in moderate-severe UC
Mercaptopurine in UC for maintenance